Exact Sciences (EXAS) Short Interest Ratio & Short Volume → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free EXAS Stock Alerts $50.38 -1.57 (-3.02%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Exact Sciences Short Interest DataCurrent Short Volume8,880,000 sharesPrevious Short Volume9,890,000 sharesChange Vs. Previous Month-10.21%Dollar Volume Sold Short$527.03 millionShort Interest Ratio / Days to Cover3.6Last Record DateApril 30, 2024Outstanding Shares184,530,000 sharesPercentage of Shares Shorted4.81%Today's Trading Volume2,453,347 sharesAverage Trading Volume2,916,506 sharesToday's Volume Vs. Average84% Short Selling Exact Sciences ? Sign up to receive the latest short interest report for Exact Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEXAS Short Interest Over TimeEXAS Days to Cover Over TimeEXAS Percentage of Float Shorted Over Time Ad InvestorPlaceBible Shocker: Have You Seen Elon Musk’s Miracle?Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process.Click here for the full story… Exact Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20248,880,000 shares $527.03 million -10.2%N/A3.6 $59.35 4/15/20249,890,000 shares $646.31 million +56.0%N/A4.1 $65.35 3/31/20246,340,000 shares $437.84 million -2.8%N/A2.8 $69.06 3/15/20246,520,000 shares $376.27 million -7.4%N/A3.4 $57.71 2/29/20247,040,000 shares $405.01 million -3.2%N/A3.6 $57.53 2/15/20247,270,000 shares $444.12 million -0.3%N/A4 $61.09 Get the Latest News and Ratings for EXAS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Exact Sciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/20247,290,000 shares $476.77 million -4.1%N/A4.3 $65.40 1/15/20247,600,000 shares $510.11 million +1.3%N/A4.6 $67.12 12/31/20237,500,000 shares $554.85 million +5.8%N/A4.5 $73.98 12/15/20237,090,000 shares $467.23 million -3.5%N/A4.4 $65.90 11/30/20237,350,000 shares $470.40 million +0.8%N/A5.1 $64.00 11/15/20237,290,000 shares $460.14 million -3.7%N/A5.1 $63.12 10/31/20237,570,000 shares $466.24 million -7.3%N/A5.4 $61.59 10/15/20238,170,000 shares $533.26 million +7.8%N/A5.8 $65.27 9/30/20237,580,000 shares $517.11 million -11.7%N/A5.3 $68.22 9/15/20238,580,000 shares $657.91 million +0.4%N/A6.3 $76.68 8/31/20238,550,000 shares $715.38 million +1.9%N/A5.5 $83.67 8/15/20238,390,000 shares $721.71 million -2.9%N/A5.2 $86.02 7/31/20238,640,000 shares $842.75 million -4.4%N/A4.7 $97.54 7/15/20239,040,000 shares $875.70 million +1.8%N/A5.1 $96.87 6/30/20238,880,000 shares $833.83 million -13.0%N/A5 $93.90 6/15/202310,210,000 shares $953.51 million +8.9%N/A5.4 $93.39 5/31/20239,380,000 shares $765.22 million -4.4%N/A5 $81.58 5/15/20239,810,000 shares $793.92 million -11.7%N/A4.7 $80.93 4/30/202311,110,000 shares $711.82 million -3.2%N/A5.8 $64.07 4/15/202311,480,000 shares $766.75 million -2.7%N/A5.7 $66.79 3/31/202311,800,000 shares $800.16 million -4.7%N/A4.8 $67.81 3/15/202312,380,000 shares $796.78 million -5.3%N/A4.9 $64.36 2/28/202313,070,000 shares $814.65 million +18.2%N/A4.9 $62.33 2/15/202311,060,000 shares $731.51 million -7.0%N/A4.4 $66.14 1/31/202311,890,000 shares $802.81 million -7.5%N/A4.6 $67.52 1/15/202312,850,000 shares $886.14 million +11.8%N/A4.8 $68.96 12/30/202211,490,000 shares $568.87 million +15.1%N/A4.6 $49.51 12/15/20229,980,000 shares $445.21 million -1.4%N/A4.2 $44.61 11/30/202210,120,000 shares $454.89 million +2.0%N/A4.7 $44.95 11/15/20229,920,000 shares $439.26 million -2.6%N/A4.4 $44.28 10/31/202210,180,000 shares $354.06 million -4.1%N/A4.3 $34.78 10/15/202210,620,000 shares $322.32 million -9.2%N/A4.7 $30.35 9/30/202211,690,000 shares $379.81 million +4.2%N/A5.4 $32.49 9/15/202211,220,000 shares $458.79 million +14.0%N/A5.2 $40.89get a piece of the profit from this land (Ad)This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. EXAS Short Interest - Frequently Asked Questions What is Exact Sciences' current short interest? Short interest is the volume of Exact Sciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 8,880,000 shares of EXAS short. Learn More on Exact Sciences' current short interest. What is a good short interest ratio for Exact Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EXAS shares currently have a short interest ratio of 4.0. Learn More on Exact Sciences's short interest ratio. Which institutional investors are shorting Exact Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Exact Sciences: Walleye Trading LLC, Jane Street Group LLC, Torno Capital LLC, Twin Tree Management LP, Concourse Financial Group Securities Inc., Simplex Trading LLC, and Goldman Sachs Group Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Exact Sciences' short interest increasing or decreasing? Exact Sciences saw a decline in short interest in April. As of April 30th, there was short interest totaling 8,880,000 shares, a decline of 10.2% from the previous total of 9,890,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Exact Sciences' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Exact Sciences: Natera, Inc. (5.02%), Exelixis, Inc. (3.35%), Quest Diagnostics Incorporated (2.53%), RadNet, Inc. (4.36%), Guardant Health, Inc. (8.30%), Fortrea Holdings Inc. (7.41%), Laboratory Co. of America Holdings (2.47%), Teleflex Incorporated (1.25%), Catalent, Inc. (3.67%), Qiagen (1.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Exact Sciences stock? Short selling EXAS is an investing strategy that aims to generate trading profit from Exact Sciences as its price is falling. EXAS shares are trading down $1.57 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Exact Sciences? A short squeeze for Exact Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EXAS, which in turn drives the price of the stock up even further. How often is Exact Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EXAS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: NTRA Short Interest Data EXEL Short Interest Data DGX Short Interest Data RDNT Short Interest Data GH Short Interest Data FTRE Short Interest Data LH Short Interest Data TFX Short Interest Data CTLT Short Interest Data QGEN Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EXAS) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceHow Biden has already won 2024Porter & Company